New results from the phase 1 clinical trial, now published in the journal Nature, show that the therapeutic cancer vaccine activated tumor-specific immune cells that persisted in the body up to nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback